Financhill
Buy
52

AMRC Quote, Financials, Valuation and Earnings

Last price:
$13.78
Seasonality move :
6.29%
Day range:
$13.76 - $14.31
52-week range:
$8.49 - $39.68
Dividend yield:
0%
P/E ratio:
13.51x
P/S ratio:
0.40x
P/B ratio:
0.72x
Volume:
552.5K
Avg. volume:
694.2K
1-year change:
-62.12%
Market cap:
$724.9M
Revenue:
$1.8B
EPS (TTM):
$1.02

Earnings Data

Next earnings date for AMRC
Aug 05
2025
Most recent earnings per share
-$0.10
Beat by $0.15
(May 5/2025)
Consensus Estimate
-$0.25
(May 5/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

AMRC Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/05/2025 Q2 $415M -- -- $0.06 --
05/05/2025 Q1 $310.9M $352.8M -$0.10 -$0.25 $0.15
02/27/2025 Q4 $525.1M $532.7M $0.70 $0.80 -$0.10
11/07/2024 Q3 $486.5M $500.9M $0.33 $0.53 -$0.20
08/05/2024 Q2 $376.1M $438M $0.09 $0.26 -$0.17
05/07/2024 Q1 $263.3M $298.4M -$0.06 -$0.06 $0.00
02/28/2024 Q4 $400M $441.4M $0.63 $0.59 $0.04
11/06/2023 Q3 -- -- $0.40 $0.46 -$0.06
07/31/2023 Q2 -- -- $0.12 $0.18 -$0.06
05/01/2023 Q1 -- -- $0.02 $0.04 -$0.02
02/27/2023 Q4 -- -- $0.34 $0.38 -$0.04
11/01/2022 Q3 -- -- $0.51 $0.70 -$0.19
08/01/2022 Q2 -- -- $0.61 $0.45 $0.16
05/02/2022 Q1 -- -- $0.32 $0.28 $0.04
02/28/2022 Q4 -- -- $0.53 $0.43 $0.10
11/01/2021 Q3 -- -- $0.33 $0.33 -$0.00
08/02/2021 Q2 -- -- $0.26 $0.26 $0.00
05/04/2021 Q1 -- -- $0.22 $0.10 $0.12
03/01/2021 Q4 -- -- $0.47 $0.29 $0.18
11/02/2020 Q3 -- -- $0.41 $0.25 $0.16
08/03/2020 Q2 -- -- $0.09 $0.07 $0.03
05/04/2020 Q1 -- -- $0.13 $0.08 $0.05
03/02/2020 Q4 -- -- $0.46 $0.39 $0.07
11/05/2019 Q3 -- -- $0.19 $0.26 -$0.07
08/08/2019 Q2 -- -- $0.18 $0.15 $0.03
04/30/2019 Q1 -- -- $0.02 -$0.02 $0.04
03/06/2019 Q4 -- -- $0.23 $0.18 $0.05
10/30/2018 Q3 -- -- $0.23 $0.15 $0.08
08/07/2018 Q2 -- -- $0.18 $0.11 $0.08
05/01/2018 Q1 -- -- $0.16 $0.05 $0.11
03/06/2018 Q4 -- -- $0.48 $0.14 $0.34
10/31/2017 Q3 -- -- $0.18 $0.15 $0.03
07/18/2017 Q2 -- -- $0.13 $0.07 $0.06
05/02/2017 Q1 -- -- -$0.01 $0.03 -$0.04
03/02/2017 Q4 -- -- $0.08 $0.03 $0.05
11/01/2016 Q3 -- -- $0.16 $0.07 $0.09
08/09/2016 Q2 -- -- $0.08 $0.04 $0.04
05/05/2016 Q1 -- -- $0.03 -- --
03/03/2016 Q4 -- -- $0.09 $0.10 -$0.01
11/05/2015 Q3 -- -- $0.09 $0.12 -$0.03
07/30/2015 Q2 -- -- $0.04 $0.01 $0.03

Ameresco Earnings Questions

  • How Much did Ameresco Generate in Revenue Last Quarter?

    Ameresco reported $352.8M worth of top line sales in its most recent quarter.

  • Did Ameresco Beat Earnings Last Quarter?

    Ameresco announced earnings per share of -$0.10 which represents a beat of analyst forecast a -$0.25 per share.

  • Is Ameresco Profitable?

    Ameresco reported $51.9M that represents $0.99 per share over the last quarter.

  • What is the Analyst Consensus for Ameresco EPS Next Year?

    Ameresco's earnings are forecast to decrease from $1.07 per share to $0.89 per share next year representing a decrease of -18.1%.

  • When is Ameresco's Earnings Date?

    Ameresco's next earnings date is August 5, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Where Will Salesforce Stock Be in 5 Years?
Where Will Salesforce Stock Be in 5 Years?

Salesforce (NYSE: CRM) just turned in a quarter that, on…

2 Ultra Safe Dividend Stocks to Buy Now
2 Ultra Safe Dividend Stocks to Buy Now

Historically, blue-chip dividend stocks have been good choices for periods…

Where Will Asana Stock Be in 5 Years?
Where Will Asana Stock Be in 5 Years?

Asana stock hasn’t given many investors on Wall Street any…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Buy
65
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Sell
31
REGN alert for May 31

Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.

Buy
55
RGC alert for May 31

Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.

Sell
42
AMBA alert for May 31

Ambarella [AMBA] is down 15.13% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock